DK1651596T3 - Hidtil ukendte derivater af 4,4'-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der omfatter samme - Google Patents
Hidtil ukendte derivater af 4,4'-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der omfatter sammeInfo
- Publication number
- DK1651596T3 DK1651596T3 DK04786279.2T DK04786279T DK1651596T3 DK 1651596 T3 DK1651596 T3 DK 1651596T3 DK 04786279 T DK04786279 T DK 04786279T DK 1651596 T3 DK1651596 T3 DK 1651596T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminobutane
- dithiobis
- sulfonates
- compositions
- same
- Prior art date
Links
- HZHMBNYJWQUCHI-UHFFFAOYSA-N 3-aminobutane-1-sulfonic acid Chemical class CC(N)CCS(O)(=O)=O HZHMBNYJWQUCHI-UHFFFAOYSA-N 0.000 title 1
- ZTVZLYBCZNMWCF-UHFFFAOYSA-N homocystine Chemical class [O-]C(=O)C([NH3+])CCSSCCC([NH3+])C([O-])=O ZTVZLYBCZNMWCF-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000037849 arterial hypertension Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0309700A FR2858617A1 (fr) | 2003-08-06 | 2003-08-06 | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| PCT/FR2004/002106 WO2005014535A1 (fr) | 2003-08-06 | 2004-08-06 | Derives de 4,4’-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1651596T3 true DK1651596T3 (da) | 2010-05-10 |
Family
ID=34073059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04786279.2T DK1651596T3 (da) | 2003-08-06 | 2004-08-06 | Hidtil ukendte derivater af 4,4'-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der omfatter samme |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7582797B2 (da) |
| EP (1) | EP1651596B1 (da) |
| JP (1) | JP4718461B2 (da) |
| AT (1) | ATE455097T1 (da) |
| CA (1) | CA2533432C (da) |
| CY (1) | CY1109950T1 (da) |
| DE (1) | DE602004025119D1 (da) |
| DK (1) | DK1651596T3 (da) |
| ES (1) | ES2339354T3 (da) |
| FR (1) | FR2858617A1 (da) |
| PL (1) | PL1651596T3 (da) |
| PT (1) | PT1651596E (da) |
| SI (1) | SI1651596T1 (da) |
| WO (1) | WO2005014535A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
| AU2009276343A1 (en) * | 2008-08-01 | 2010-02-04 | Bioxiness Pharmaceuticals, Inc. | Methionine analogs and methods of using same |
| EP2439192A1 (en) * | 2010-10-07 | 2012-04-11 | Quantum Genomics | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) |
| JP6212500B2 (ja) | 2011-12-21 | 2017-10-11 | クァンタム ジェノミックＱｕａｎｔｕｍ Ｇｅｎｏｍｉｃｓ | （３ｓ，３ｓ’）４，４’−ジスルファンジイルビス（３−アミノブタン１−スルホン酸）および第２の抗高血圧剤の組合せ |
| EP2722327A1 (en) | 2012-10-22 | 2014-04-23 | Quantum Genomics | Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine |
| CA2964474A1 (en) * | 2014-10-17 | 2016-04-21 | University Of Florida Research Foundation | Novel small molecule anticancer agents |
| TW202100146A (zh) | 2019-03-11 | 2021-01-01 | 法商量子基因科技有限公司 | 用於治療高血壓或心衰竭的化合物及包含其之組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5021134A1 (es) * | 1998-05-01 | 2001-03-27 | Abbott Lab | Inhibidores beta-aminoacidos substituidos de aminopeptida- sa-2 metionina |
| US6919307B2 (en) * | 2000-11-01 | 2005-07-19 | Praecis Pharmaceuticals, Inc. | Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| WO2002078697A1 (en) * | 2001-03-29 | 2002-10-10 | Smithkline Beecham Corporation | Compounds and methods |
-
2003
- 2003-08-06 FR FR0309700A patent/FR2858617A1/fr not_active Withdrawn
-
2004
- 2004-08-06 AT AT04786279T patent/ATE455097T1/de active
- 2004-08-06 CA CA2533432A patent/CA2533432C/fr not_active Expired - Fee Related
- 2004-08-06 EP EP04786279A patent/EP1651596B1/fr not_active Expired - Lifetime
- 2004-08-06 US US10/567,362 patent/US7582797B2/en not_active Expired - Lifetime
- 2004-08-06 ES ES04786279T patent/ES2339354T3/es not_active Expired - Lifetime
- 2004-08-06 PL PL04786279T patent/PL1651596T3/pl unknown
- 2004-08-06 WO PCT/FR2004/002106 patent/WO2005014535A1/fr not_active Ceased
- 2004-08-06 DK DK04786279.2T patent/DK1651596T3/da active
- 2004-08-06 PT PT04786279T patent/PT1651596E/pt unknown
- 2004-08-06 JP JP2006522380A patent/JP4718461B2/ja not_active Expired - Fee Related
- 2004-08-06 SI SI200431385T patent/SI1651596T1/sl unknown
- 2004-08-06 DE DE602004025119T patent/DE602004025119D1/de not_active Expired - Lifetime
-
2010
- 2010-03-23 CY CY20101100285T patent/CY1109950T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1651596E (pt) | 2010-04-16 |
| ATE455097T1 (de) | 2010-01-15 |
| JP4718461B2 (ja) | 2011-07-06 |
| SI1651596T1 (sl) | 2010-06-30 |
| CA2533432C (fr) | 2013-05-21 |
| EP1651596B1 (fr) | 2010-01-13 |
| US20060205695A1 (en) | 2006-09-14 |
| DE602004025119D1 (de) | 2010-03-04 |
| FR2858617A1 (fr) | 2005-02-11 |
| JP2007501204A (ja) | 2007-01-25 |
| EP1651596A1 (fr) | 2006-05-03 |
| WO2005014535A1 (fr) | 2005-02-17 |
| PL1651596T3 (pl) | 2010-08-31 |
| US7582797B2 (en) | 2009-09-01 |
| ES2339354T3 (es) | 2010-05-19 |
| CA2533432A1 (fr) | 2005-02-17 |
| CY1109950T1 (el) | 2014-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300877I2 (nl) | obeticholzuur | |
| EA200601007A1 (ru) | 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы | |
| EA200601002A1 (ru) | 6-алкенил и 6-фенилалкил замещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы | |
| DK1663185T3 (da) | Forebyggelse og behandling af inflammationsinduceret og/eller immun-medieret knogletab | |
| CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
| NO20063479L (no) | Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| WO2004004657A3 (en) | Hiv integrase inhibitors | |
| EA200601125A1 (ru) | 6-замещённые циклогексилалкил 2-замещённые хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(adp-рибоза)полимеразы | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| DK1696905T3 (da) | Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson | |
| PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
| CY1109950T1 (el) | Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν | |
| DE60031886D1 (de) | Purinderivate | |
| DK1373220T3 (da) | Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion | |
| DE60336735D1 (de) | Neue biologischaktive molekü le | |
| ATE443044T1 (de) | Tace inhibitoren | |
| EA200600018A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов фдэ4 | |
| EP1667976A4 (en) | Isoquinolinone POTASSIUM CHANNEL INHIBITORS | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| UA88867C2 (ru) | Композиция, которая содержит модафинил, и ее применение | |
| TW200616977A (en) | Enantiomers of selected fused heterocyclics and uses thereof |